Tighter Inspection Provisions In Dingell Safety Bill Could Follow Ranbaxy Alert

House Energy and Commerce Committee Chairman John Dingell likely will strengthen FDA mandates proposed in his evolving global drug safety bill in light of the agency's import alert for Ranbaxy products, including an OTC drug